U.S. stocks finished mostly higher Thursday, but pulled back from record intraday highs on a report of distribution issues with Pfizer's coronavirus vaccine...
The prominent hedge-fund luminary has been among the traditional investors who is considered in the decidedly bullish cryptocurrency camp and sees big...
A November fund flow report from data provider Refinitiv Lipper shows how investors increasingly embraced risk and started to rotate toward cyclical corners of...
Did a record coronavirus outbreak trigger the first drop in U.S. employment in November since the onset of the pandemic last spring? Some economists think so...
Gold futures climbed for a third day in a row on Thursday to mark their highest settlement in almost two weeks amid persistent weakness in the U.S. dollar and...
'No, I never considered it was risky, and no, of course, I’m not getting paid. I just received my second shot a few days ago,' writes Pierre Briançon of...
In a year in which hedge funds have struggled to deliver the goods to investors, one "Tiger cub" has seen his assets under management explode thanks in large...
The large service side of the U.S. economy mostly brushed off a record surge in coronavirus cases in November, but business leaders expressed greater worries...
Abercrombie & Fitch stock is up more than 62% over the past three months.
Read More...
The U.K. has approved the COVID-19 vaccine from Pfizer and BioNTech, paving the way for vaccinations to begin weeks ahead of much of the rest of the world...
